Status
Conditions
Treatments
About
Purpose The purpose of this study is to investigate the effects of discontinuation of sugar sweetened beverages on hemoglobin A1c (HbA1c) and plasma fasting and post-prandial blood glucose in a population with type 2 diabetes.
Hypothesis Elimination of sugar sweetened beverages from the diet for a 4 week period will lead to a decrease in HbA1c and plasma fasting and 2 hour post prandial blood glucose in a population with a history of type 2 diabetes and high consumption of sugar sweetened beverages.
Specific aims to test hypothesis
Full description
Type and Design of Study This will be a pilot study including adult patients age >/= 18 diagnosed with Type 2 Diabetes who are patients at the Duke Outpatient Clinic (DOC) or patients in the general medicine or family practice clinics in Durham County. The intervention will be elimination of sugar sweetened beverages from the diet in a population of type 2 diabetic subjects for four weeks. Sugar sweetened beverages will be defined as any liquid beverage containing calories that can be attributed to natural or added sugar. This will not include beverages that contain mainly artificial sweeteners (e.g.: NutraSweet®, saccharin, Splenda®, or Equal®), plain milk, or water.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Prior diagnosis of Type 2 Diabetes for at least 1 year based on one of the following:
Age >/=18
Stable but uncontrolled blood glucose (Hemoglobin A1C >7%, </= 12%)
Ingestion of at least three eight ounce servings of sugar sweetened beverage daily.
Stable solid diet and exercise pattern and agreement not to change these during the study
Able and willing to maintain a complete diet diary for three days each week of the study (total of 12 days of recording)
Able to attend regular study visits
Able to give informed consent
Working phone number in order to contact patient
Able and willing to understand and comply with the intervention
Exclusion criteria
5 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal